APONTIS - Ownership and Business Overview

Life ScienceCompany

APONTIS Ownership

Who owns APONTIS?

APONTIS is owned by Paragon Partners. It was acquired on July 30, 2018.

Is APONTIS PE-backed?

Yes. APONTIS is owned by private equity investor Paragon Partners.

APONTIS Business Overview

Where is APONTIS headquartered?

APONTIS is headquartered in Monheim am Rhein, Germany.

How many employees does APONTIS have?

APONTIS has 200 employees.

What sector is APONTIS in?

APONTIS is a life science company.

When was APONTIS founded?

APONTIS was founded in 2016.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

APONTIS

APONTIS PHARMA GmbH & Co. KG

Rolf-Schwarz-Schutte-Platz 1,
Monheim am Rhein, 40789
Germany,
+49 2173 48 4949
www.apontis-pharma.de

APONTIS is a supplier of pharmaceuticals for chronically ill patients. Next to co-marketing activities, the company focuses on the development and promotion of single pills and has established itself as a pioneer in this segment. Single pills are a combination of two to three ingredients in one single pill, which has proven to significantly increase adherence and thus patient prognoses compared to the conventional therapy with 2-3 separate pills. APONTIS was founded in 2016 and is based in Monheim, Germany.


Company Summary

SECTOR

Life Science

Employees

200

Established

2016

Former Name

UCB Innere Medizin GmbH & Co. KG

 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for APONTIS

Life Science Companies , Germany Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Germany Companies

Largest Germany Companies , Acquisitive Germany Companies , Recently Acquired Germany Companies , Recently Sold Germany Companies , Private Germany Companies , Public Germany Companies , Acquired Germany Companies , PE Backed Germany Companies
Mergr

Product

Company

Legal